Understanding factors affecting patients with obstructive pyelonephritis
Factors Associated With the Prognosis of Patients Admitted to for Acute Obstructive Pyelonephritis
Assistance Publique - Hôpitaux de Paris · NCT06299215
This study looks at patients with severe kidney infections in intensive care to see what factors might lead to worse outcomes and improve our understanding of the condition.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Ages | 18 Years to 100 Years |
| Sex | All |
| Sponsor | Assistance Publique - Hôpitaux de Paris (other) |
| Locations | 1 site (Paris) |
| Trial ID | NCT06299215 on ClinicalTrials.gov |
What this trial studies
This observational study aims to analyze the prognosis of patients admitted to intensive care units for acute obstructive pyelonephritis. It will involve a retrospective collection of medical data from multiple centers, focusing on patients treated between 2015 and 2022. The goal is to identify factors that contribute to poor outcomes in these patients, thereby enhancing understanding of this serious condition. By aggregating data from various hospitals, the study seeks to provide a more comprehensive view than previous smaller studies.
Who should consider this trial
Good fit: Ideal candidates for this study are adults over 18 years old who have been hospitalized in intensive care for acute obstructive pyelonephritis.
Not a fit: Patients who are pregnant, oppose data use, or are under legal protection will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved management strategies and outcomes for patients with acute obstructive pyelonephritis.
How similar studies have performed: While smaller studies have been conducted, this large-scale, multicenter approach is novel and has not been previously tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients over 18 years of age * Hospitalized in intensive care for management of acute obstructive pyelonephritis * Patients affiliated to a Social Security System Exclusion Criteria: * Pregnancy * Opposition to data use * Persons under legal protection (curatorship, guardianship), legal safeguards
Where this trial is running
Paris
- Hospital Saint Louis — Paris, France (RECRUITING)
Study contacts
- Principal investigator: Maxime Dr COUTROT, MD — Hopital saint Louis-APHP
- Study coordinator: Maxime Dr COUTROT, MD
- Email: maxime.coutrot@aphp.fr
- Phone: 01 42 49 93 94
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Pyelonephritis, Prognostic, acute kidney injury, renal remplacement therapy, hemodialysis, acute respiratory distress, hemodynamic failure